利润表（悦康药业）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 3,780,875,989.99 | 2,991,795,632.65 | 1,950,036,435.86 | 967,900,022.68 | 4,196,300,749.57 | 2,957,716,328.49 | 2,199,926,860.87 | 1,128,554,211.20 |
| 营业收入(元) | 3,780,875,989.99 | 2,991,795,632.65 | 1,950,036,435.86 | 967,900,022.68 | 4,196,300,749.57 | 2,957,716,328.49 | 2,199,926,860.87 | 1,128,554,211.20 |
| 二、营业总成本(元) | 3,563,397,787.00 | 2,730,072,277.72 | 1,804,764,081.76 | 904,066,984.17 | 3,960,329,636.78 | 2,787,559,797.21 | 1,967,382,654.11 | 1,026,297,006.75 |
| 营业成本(元) | 1,595,483,109.87 | 1,185,398,827.66 | 813,080,060.11 | 455,919,694.99 | 1,566,420,246.30 | 1,054,952,148.00 | 739,248,550.81 | 442,866,442.26 |
| 研发费用(元) | 374,306,998.74 | 261,146,138.06 | 177,628,128.64 | 85,499,658.32 | 351,879,003.83 | 231,721,009.40 | 139,173,530.95 | 73,728,143.73 |
| 营业税金及附加(元) | 46,897,915.11 | 38,401,152.55 | 24,537,331.91 | 11,725,795.57 | 54,819,977.41 | 39,543,130.32 | 28,632,284.44 | 13,235,710.21 |
| 销售费用(元) | 1,301,868,005.85 | 1,077,257,545.89 | 679,465,232.64 | 294,028,028.72 | 1,767,160,867.82 | 1,301,988,273.28 | 969,119,882.88 | 443,942,248.97 |
| 管理费用(元) | 239,868,373.07 | 164,333,471.07 | 109,110,209.57 | 57,433,485.33 | 230,322,498.01 | 168,433,672.05 | 99,720,920.77 | 56,496,638.97 |
| 财务费用(元) | 4,973,384.36 | 3,535,142.49 | 943,118.89 | -539,678.76 | -10,272,956.59 | -9,078,435.84 | -8,512,515.74 | -3,972,177.39 |
| 其中：利息费用(元) | 22,395,514.29 | 17,187,238.11 | 11,422,057.79 | 5,536,181.10 | 13,211,543.00 | 9,011,366.23 | 5,679,176.30 | 2,533,945.97 |
| 三、其他经营收益 | ||||||||
| 加：公允价值变动收益(元) | 2,344,894.08 | - | - | - | -686,875.22 | - | - | - |
| 加：投资收益(元) | 442,391.76 | - | - | - | -320,697.87 | -330,842.60 | -160,883.97 | - |
| 资产处置收益(元) | -383,536.49 | 29,443.79 | 205,252.61 | -606.84 | 1,043,142.40 | 1,018,276.86 | 1,143,563.80 | 1,143,563.80 |
| 资产减值损失(元) | -100,545,979.23 | -34,174,805.44 | -20,450,476.94 | 6,332,341.06 | -62,405,526.20 | -38,201,739.97 | -18,696,649.06 | -14,198,528.59 |
| 信用减值损失(元) | 6,264,713.36 | 4,478,983.30 | 7,118,137.28 | 3,420,596.90 | 13,726,834.35 | 18,758,139.37 | 8,318,902.78 | 2,953,279.56 |
| 其他收益(元) | 33,462,220.90 | 22,915,446.94 | 12,551,195.09 | 6,779,575.39 | 44,424,760.57 | 21,062,189.52 | 11,696,176.16 | 4,153,004.89 |
| 四、营业利润(元) | 159,062,907.37 | 254,972,423.52 | 144,696,462.14 | 80,364,945.02 | 231,752,750.82 | 172,462,554.46 | 234,845,316.47 | 96,308,524.11 |
| 加：营业外收入(元) | 4,026,558.96 | 2,166,091.78 | 1,554,283.32 | 372,202.91 | 2,006,098.39 | 1,455,729.44 | 812,102.32 | 38,360.42 |
| 减：营业外支出(元) | 10,731,858.98 | 8,868,118.92 | 7,711,325.86 | 1,621,499.80 | 10,490,585.25 | 8,157,178.55 | 6,506,083.73 | 3,104,730.55 |
| 五、利润总额(元) | 152,357,607.35 | 248,270,396.38 | 138,539,419.60 | 79,115,648.13 | 223,268,263.96 | 165,761,105.35 | 229,151,335.06 | 93,242,153.98 |
| 减：所得税费用(元) | 31,110,723.46 | 40,069,856.69 | 20,593,626.53 | 9,991,362.91 | 35,774,173.43 | 11,136,845.63 | 20,518,074.06 | 7,709,154.67 |
| 六、净利润(元) | 121,246,883.89 | 208,200,539.69 | 117,945,793.07 | 69,124,285.22 | 187,494,090.53 | 154,624,259.72 | 208,633,261.00 | 85,532,999.31 |
| (一)按经营持续性分类 | ||||||||
| 持续经营净利润(元) | 121,246,883.89 | 208,200,539.69 | 117,945,793.07 | 69,124,285.22 | 187,494,090.53 | 154,624,259.72 | 208,633,261.00 | 85,532,999.31 |
| (二)按所有权归属分类 | ||||||||
| 归属于母公司股东的净利润(元) | 123,717,028.86 | 209,725,063.28 | 118,553,513.19 | 69,305,423.83 | 184,795,719.38 | 152,274,748.25 | 207,076,436.29 | 85,267,722.97 |
| 少数股东损益(元) | -2,470,144.97 | -1,524,523.59 | -607,720.12 | -181,138.61 | 2,698,371.15 | 2,349,511.47 | 1,556,824.71 | 265,276.34 |
| 扣除非经常性损益后的净利润(元) | 110,758,662.86 | 201,930,530.98 | 116,811,790.14 | 64,647,274.96 | 132,369,156.47 | 138,405,919.63 | 200,026,528.73 | 83,120,811.26 |
| 七、每股收益 | ||||||||
| 一、基本每股收益(元) | 0.28 | 0.47 | 0.26 | 0.15 | 0.41 | 0.34 | 0.46 | 0.19 |
| 二、稀释每股收益(元) | 0.28 | 0.47 | 0.26 | 0.15 | 0.41 | 0.34 | 0.46 | 0.19 |
| 九、综合收益总额(元) | 121,246,883.89 | 208,200,539.69 | 117,945,793.07 | 69,124,285.22 | 187,494,090.53 | 154,624,259.72 | 208,633,261.00 | 85,532,999.31 |
| 归属于母公司所有者的综合收益总额(元) | 123,717,028.86 | 209,725,063.28 | 118,553,513.19 | 69,305,423.83 | 184,795,719.38 | 152,274,748.25 | 207,076,436.29 | 85,267,722.97 |
| 归属于少数股东的综合收益总额(元) | -2,470,144.97 | -1,524,523.59 | -607,720.12 | -181,138.61 | 2,698,371.15 | 2,349,511.47 | 1,556,824.71 | 265,276.34 |
| 公告日期 | 2025-03-15 | 2024-10-31 | 2024-08-23 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-18 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | - | - | - | 标准无保留意见 | - | - | - |
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 40 of 40 entries